|
Volumn 33, Issue 3, 2001, Pages 2304-2306
|
Low rejection rate with high-dose ATG bolus therapy in simultaneous pancreas and kidney transplantation
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
LYMPHOCYTE ANTIBODY;
ADULT;
ARTICLE;
CHRONIC KIDNEY FAILURE;
DIABETIC NEPHROPATHY;
DISEASE FREE SURVIVAL;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMAN;
IMMUNOLOGY;
INSULIN DEPENDENT DIABETES MELLITUS;
INTRAVENOUS DRUG ADMINISTRATION;
KIDNEY TRANSPLANTATION;
LYMPHOCYTE COUNT;
MALE;
METHODOLOGY;
MORTALITY;
PANCREAS TRANSPLANTATION;
RETROSPECTIVE STUDY;
SURVIVAL RATE;
THROMBOCYTE COUNT;
TIME;
ADULT;
ANTILYMPHOCYTE SERUM;
DIABETES MELLITUS, TYPE 1;
DIABETIC NEPHROPATHIES;
DISEASE-FREE SURVIVAL;
FEMALE;
GRAFT REJECTION;
GRAFT SURVIVAL;
HUMANS;
INJECTIONS, INTRAVENOUS;
KIDNEY FAILURE, CHRONIC;
KIDNEY TRANSPLANTATION;
LYMPHOCYTE COUNT;
MALE;
PANCREAS TRANSPLANTATION;
PLATELET COUNT;
RETROSPECTIVE STUDIES;
SURVIVAL RATE;
TIME FACTORS;
|
EID: 0035345399
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(01)02000-0 Document Type: Article |
Times cited : (7)
|
References (8)
|